The State of the Art in Chronic Prurigo Nodularis
Por:
Serra-Baldrich, E, Flórez, A, Manresa, MJ, de Frutos, FJO, Pereyra-Rodriguez, JJ, Pérez, B, Figueras, I
Publicada:
1 jul 2026
Ahead of Print:
1 jun 2026
Resumen:
Chronic prurigo nodularis (CPN) is a highly burdensome chronic inflammatory dermatosis characterized by intensely pruritic papulonodular lesions that may persist for years. Its pathophysiology reflects a neuro-immune-fibrotic axis in which type-2 cytokines (IL-4/IL-13/IL-31), neuropeptides, and profibrotic signaling interact to sustain the itch-scratch cycle and dermal fibrosis. CPN predominantly affects older adult women and is frequently associated with dermatologic, neuropsychiatric, and cardiometabolic comorbidities. Definition, nomenclature, and management remain areas of debate, with relevant differences between European and US consensus documents. The therapeutic landscape has expanded with dupilumab and nemolizumab, the only agents currently supported by phase III evidence, whereas JAK inhibitors remain promising but investigational options that require careful safety contextualization. This narrative review synthesizes current knowledge on CPN, from definition and epidemiology to etiopathogenesis and evolving therapy, while highlighting persistent unmet needs in diagnosis and management.
Filiaciones:
Serra-Baldrich, E:
Hosp Santa Creu & Sant Pau, Serv Dermatol, Carrer St Quinti 89, Barcelona 08025, Spain
Flórez, A:
Univ Santiago de Compostela, Hosp Univ Santiago de Compostela, Fac Med & Odontol,Inst Invest Sanitaria Santiago d, Serv Dermatol,Grp Invest Traslac Enfermedades Derm, Santiago De Compostela, Spain
Manresa, MJ:
Hosp Univ Basurto, Serv Dermatol, Bilbao, Spain
Inst Invest Sanitaria Biobizkaia, Bilbao, Spain
de Frutos, FJO:
Hosp Univ 12 Octubre, Serv Dermatol, Madrid, Spain
Pereyra-Rodriguez, JJ:
Univ Seville, Hosp Univ Virgen del Rocio, Fac Med, Dept Med,Serv Dermatol, Seville, Spain
Pérez, B:
Hosp Univ Ramon & Cajal, Serv Dermatol, Madrid, Spain
Figueras, I:
Hosp Univ Bellvitge, Serv Dermatol, Barcelona, Spain
Green Submitted, gold
|